CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Nephropathy

Renal & ElectrolyteDisease / conditionriskpartially modifiable
17
evidence score
PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 14.4genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (27)

NCTTitleStatusTypeInterventions
NCT04662723Multicentre Prospective Open Label Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.RECRUITINGINTERVENTIONALCorticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose cotransporter 2 inhibitor
NCT06501651A Prospective, Randomized, Controlled, Multicenter Study of Sacubitril/Valsartan in the Treatment of Patients With Mild to Moderate Essential Hypertension and Type 2 Diabetic Nephropathy: The Hyper-Save StudyNOT YET RECRUITINGINTERVENTIONALSacubitril/Valsartan, Valsartan
NCT04027530Phase 4, Randomized, Placebo-controlled, Cross-over Trial to Assess the Effect of 4-week Ertugliflozin (SGLT-2 Inhibitor) Therapy on Renal Oxygenation by BOLD-MRI and Renal Oxygen Consumption by PET Using ¹¹C-acetate in T2DM Without Kidney Disease and Healthy Controls.COMPLETEDINTERVENTIONALErtugliflozin 15 mg
NCT04127084Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes: a Prospective Interventional StudyUNKNOWNINTERVENTIONALSGLT2 Inhibition
NCT03755700Antioxidants for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery CatheterizationUNKNOWNINTERVENTIONALVitamin E, N-acetyl cysteine, Placebo oral capsule
NCT03391830Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled StudyCOMPLETEDINTERVENTIONALAtorvastatin-Ascorbic acid, Placebo
NCT04705506Effect of Gemigliptin on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Nephropathy: A Randomized Controlled TrialCOMPLETEDINTERVENTIONALGemigliptin
NCT02442921The Effect of Colchicine Treatment on the Progression of Proteinuria in Patients With Diabetic Nephropathy.UNKNOWNINTERVENTIONALColchicine, Placebo
NCT02575092Department of GeriatricsCOMPLETEDINTERVENTIONALEnalapril Maleate Tablets(as the program-based antihypertension), Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension), Placebo
NCT02065791A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic NephropathyCOMPLETEDINTERVENTIONALCanagliflozin, Placebo
NCT02035891Low-dose Colchicine Intervention in Patients With Type 2 Diabetes Mellitus and Microalbuminuria: Chongqing StudyUNKNOWNINTERVENTIONALcolchicine 0.5mg/d, placebo 0.5mg/d
NCT01588795Renal Denervation in Patients With Diabetic Nephropathy and Persistent ProteinuriaCOMPLETEDINTERVENTIONALPercutaneous renal denervation and TMNS, Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
NCT02113540Atorvastatin and Prevention of Contrast Induced Nephropathy Following Coronary AngiographyUNKNOWNINTERVENTIONALAtorvastatin
NCT02471599Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy :a Prospective,Randomized,Controlled Study.SUSPENDEDINTERVENTIONALtonsillectomy, non-tonsillectomy
NCT01093157A Dose-finding Pilot Study of ACTH (Adrenocorticotropic Hormone) on the Proteinuria and Serum Lipoprotein Profile in Patients With Idiopathic Membranous Nephropathy (MN)COMPLETEDINTERVENTIONALAdrenocorticotrophic hormone ACTH
NCT00805753A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)COMPLETEDINTERVENTIONALACTH
NCT00554502Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA NephropathyCOMPLETEDINTERVENTIONALsupportive therapy with: ACE-inhibitor / ARB / Statin, supportive and immunosuppressive therapy
NCT00461136An Open-label, One-period, One-treatment Study to Evaluate the Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes Suffering From Incipient and/or Established NephropathyCOMPLETEDINTERVENTIONALAliskiren
NCT00199927A Prospective, Randomized, Multicenter Trial Testing the Antiproteinuric Effect of Statins Added to Combined ACE-inhibitor and Angiotensin Receptor Antagonist Therapy in Proteinuric, Chronic NephropathiesCOMPLETEDINTERVENTIONALFluvastatin, standard therapy
NCT07444203Transformative Research in Diabetic Nephropathy 2.0: A Proof of Principle Study of SGLT2 Inhibitors (TRIDENT 2.0)RECRUITINGOBSERVATIONALSodium-glucose cotransporter 2 inhibitors (SGLT2i), Renin-angiotensin-aldosterone system blockade, Glucagon-like peptide-1 receptor agonists (GLP 1 RA)
NCT06065852National Registry of Rare Kidney Diseases (RaDaR)RECRUITINGOBSERVATIONAL
NCT07476248The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes MellitusNOT YET RECRUITINGOBSERVATIONAL
NCT05047471Healthy China - The Improvement Projects for the Screening Ability of Diabetes and Its Complications And for the Standardized Ability of Diagnosis and Treatment for Patients With Early Diabetic NephropathyUNKNOWNOBSERVATIONAL
NCT04163484Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery DiseaseCOMPLETEDOBSERVATIONALIodinated contrast
NCT02192372Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary InterventionCOMPLETEDOBSERVATIONAL
NCT00842868The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker StudyCOMPLETEDOBSERVATIONAL
NCT00498147Does Managed Diabetes Care Decrease Cardiovascular Complications of Diabetes?UNKNOWNOBSERVATIONALADEC Program

Genetic associations (0)

None linked.